CME Symposium- Stable Ischemic Heart Disease Management: Challenges and Controversies

CHICAGO - Oct. 16, 2014 - PRLog -- Click to Register Online

Stable Ischemic Heart Disease Management:
Challenges and Controversies

Valentin Fuster (Co-Chair)
Professor of Medicine
Icahn School of Medicine
   at Mount Sinai
New York, New York

Peter Stone, MD (Co-Chair)
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Mikhail Kosiborod, MD
Professor of Medcine
University of Missouri Kansas City
  School of Medicine
Kansas City, Missouri

L. Kristin Newby, MD, MHS
Professor of Medicine
Duke University
Durham, North Carolina

Duane Pinto, MD, MPH
Assistant Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Click to Register Online

The evolution of stable ischemic heart disease (SIHD) management has included changes and new information in all aspects of management, including but not limited to diagnosis and assessment of risk, guideline directed medical therapy (GDMT), cardiometabolic risk factor control, when to revascularize the SIHD patient, and when revascularization is selected, and decision-making regarding percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG). SIHD guidelines indicate that the objectives of treatment are to 1) reduce premature cardiovascular death; 2) prevent complications of SIHD that directly or indirectly impair patients’ functional well-being, including nonfatal acute myocardial infarction (AMI) and heart failure; 3) maintain or restore a level of activity, functional capacity, and quality of life that is satisfactory to the patient; 4) completely, or nearly completely, eliminate ischemic symptoms; and 5) minimize costs of health care, in particular by eliminating avoidable adverse effects of tests and treatments, by preventing hospital admissions, and by eliminating unnecessary tests and treatments. In this program, a faculty of experts—co-Chairs Dr. Valentin Fuster and Dr. Peter Stone, Dr. Mikhail Kosiborod, Dr. L. Kristin Newby, and Dr. Duane Pinto—will describe state-of-the-art management with GDMT and revascularization, discuss current controversies, and debate best practice in challenging cases of SIHD patients.

Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Voxmedia LLC designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Voxmedia gratefully acknowledges the educational grant provided by Gilead Sciences Medical Affairs.

This educational activity is intended for general and interventional cardiologists.

Pre-registration is for planning purposes only.

For additional CME activities and online cme courses visit CMEPlanet